Literature DB >> 29577868

Regulation of Smooth Muscle Myosin Light Chain Phosphatase by Multisite Phosphorylation of the Myosin Targeting Subunit, MYPT1.

Justin A MacDonald1, Michael P Walsh1.   

Abstract

BACKGROUND: Smooth muscle contraction is triggered primarily by activation of Ca2+/calmodulin-dependent myosin light chain kinase leading to phosphorylation of the regulatory light chains of myosin II. Numerous contractile stimuli also induce inhibition of myosin light chain phosphatase thereby prolonging the contractile response. The phosphatase is a trimeric enzyme containing a catalytic subunit, a regulatory, myosin-binding subunit (MYPT1) and a third subunit of uncertain function. MYPT1 is phosphorylated at multiple sites by several kinases, which regulate phosphatase activity, protein-protein interactions and subcellular localization. The best-characterized phosphorylation events involve phosphorylation by Rho-associated coiled-coil kinase (ROCK) at T697 and T855, which inhibits phosphatase activity, and phosphorylation by cAMP- or cGMPdependent protein kinases (PKA and PKG, respectively) at S696, T697, S854 and T855, which has no effect on phosphatase activity. Furthermore, phosphorylation by ROCK at T697 and T855 prevents phosphorylation by PKA or PKG at the neighboring serine residues. Some 30 phosphorylation sites have been identified in MYPT1 with many more suggested by large-scale phosphoproteomic studies. It is important to gain as complete understanding as possible of the complex phosphorylation-mediated mechanisms of regulation of MYPT1 functions in part because of their involvement in pathological processes. For example, dysfunctional MYPT1 phosphorylation has been implicated in the pathogenesis of several vascular disorders, including type 2 diabetes.
CONCLUSION: Much effort is now being devoted to the development of novel therapeutics targeting MYPT1 and specific kinases involved in the phosphorylation of MYPT1. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  MYPT1; Rho-associated kinase; Vasoconstriction; myosin II; myosin light chain phosphatase; phosphorylation; zipper-interacting protein kinase.

Mesh:

Substances:

Year:  2018        PMID: 29577868     DOI: 10.2174/1871529X18666180326120638

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  11 in total

1.  ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer.

Authors:  Masayuki Komatsu; Hitoshi Ichikawa; Fumiko Chiwaki; Hiromi Sakamoto; Rie Komatsuzaki; Makoto Asaumi; Kazuhisa Tsunoyama; Takeo Fukagawa; Hiromichi Matsushita; Narikazu Boku; Keisuke Matsusaki; Fumitaka Takeshita; Teruhiko Yoshida; Hiroki Sasaki
Journal:  Oncogene       Date:  2022-09-20       Impact factor: 8.756

2.  Targeting Pim Kinases and DAPK3 to Control Hypertension.

Authors:  David A Carlson; Miriam R Singer; Cindy Sutherland; Clara Redondo; Leila T Alexander; Philip F Hughes; Stefan Knapp; Susan B Gurley; Matthew A Sparks; Justin A MacDonald; Timothy A J Haystead
Journal:  Cell Chem Biol       Date:  2018-07-19       Impact factor: 8.116

3.  Notch signaling regulates arterial vasoreactivity through opposing functions of Jagged1 and Dll4 in the vessel wall.

Authors:  Sanchita Basu; Iulia Barbur; Alexander Calderon; Suhanti Banerjee; Aaron Proweller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-31       Impact factor: 4.733

4.  Smoothelin-like 1 deletion enhances myogenic reactivity of mesenteric arteries with alterations in PKC and myosin phosphatase signaling.

Authors:  Sara R Turner; Mona Chappellaz; Brittany Popowich; Anne A Wooldridge; Timothy A J Haystead; William C Cole; Justin A MacDonald
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

5.  TIMAP inhibits endothelial myosin light chain phosphatase by competing with MYPT1 for the catalytic protein phosphatase 1 subunit PP1cβ.

Authors:  Xin Wang; Marya Obeidat; Laiji Li; Phuwadet Pasarj; Salah Aburahess; Charles F B Holmes; Barbara J Ballermann
Journal:  J Biol Chem       Date:  2019-07-17       Impact factor: 5.157

6.  Special Issue: The Actin-Myosin Interaction in Muscle: Background and Overview.

Authors:  John Squire
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

7.  Enhanced RAGE Expression and Excess Reactive-Oxygen Species Production Mediates Rho Kinase-Dependent Detrusor Overactivity After Methylglyoxal Exposure.

Authors:  Akila L Oliveira; Matheus L Medeiros; Mariana G de Oliveira; Caio Jordão Teixeira; Fabíola Z Mónica; Edson Antunes
Journal:  Front Physiol       Date:  2022-03-28       Impact factor: 4.566

8.  Hesperetin Inhibits Sphingosylphosphorylcholine-Induced Vascular Smooth Muscle Contraction by Regulating the Fyn/Rho-Kinase Pathway.

Authors:  Qian Lu; Hiroko Kishi; Ying Zhang; Tomoka Morita; Sei Kobayashi
Journal:  J Cardiovasc Pharmacol       Date:  2022-01-05       Impact factor: 3.271

9.  Complex Transcriptional Profiles of the PPP1R12A Gene in Cells of the Circulatory System as Revealed by In Silico Analysis and Reverse Transcription PCR.

Authors:  Paulo André Saldanha; Israel Olapeju Bolanle; Timothy Martin Palmer; Leonid Leonidovich Nikitenko; Francisco Rivero
Journal:  Cells       Date:  2022-07-27       Impact factor: 7.666

10.  Rho-associated kinase and zipper-interacting protein kinase, but not myosin light chain kinase, are involved in the regulation of myosin phosphorylation in serum-stimulated human arterial smooth muscle cells.

Authors:  Jing-Ti Deng; Sabreena Bhaidani; Cindy Sutherland; Justin A MacDonald; Michael P Walsh
Journal:  PLoS One       Date:  2019-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.